A REVIEW OF PENTOBARBITAL SODIUM USE

A Review Of pentobarbital sodium use

pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Coadministration of CYP3A4 inducers may possibly reduce sufentanil ranges and efficacy, potentially precipitating withdrawal syndrome in sufferers who've designed physical dependence to sufentanil. Discontinuatio

read more